Athey S, Kremer M, Snyder C, Tabarrok A. In the race for a coronavirus vaccine, we must go big. really, really big. New York Times. 2020. https://www.nytimes.com/2020/05/04/opinion/coronavirus-vaccine.html. Accessed 12 Aug 2020.
Coy P. Pay attention to nobel laureate michael kremer on the pandemic. Bloomberg Quint. 2020. https://www.bloombergquint.com/businessweek/pay-attention-to-nobel-laureate-michael-kremer-on-the-pandemic. Accessed 12 Aug 2020.
Folegatti PM, Ewer KJ, Aley PK, Angus B, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet. 2020;396(10249):467–78.
Terry M. AstraZeneca aims for 30 million doses of COVID-19 vaccine for UK by September. https://www.biospace.com/article/astrazeneca-plans-30-million-university-of-oxford-covid-19-vaccine-doses-by-september/. Accessed 12 Aug 2020.
Herper M. AstraZeneca lays out plan for producing 2 billion doses of Covid-19 vaccine, if it works. STAT. 2020. https://www.statnews.com/2020/06/04/astrazeneca-lays-out-plan-for-producing-2-billion-doses-of-covid-19-vaccine-if-it-works/. Accessed 12 Aug 2020.
Torjesen I. Pre-purchasing vaccine—sensible or selfish? BMJ. 2020;370:m3226. https://doi.org/10.1136/bmj.m3226.
Adams B. COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October. Fierce BioTech. 2020. https://www.fiercebiotech.com/biotech/covid-19-vaccine-leaders-talk-up-need-for-partners-potential-for-a-working-vax-by-october. Accessed 12 Aug 2020.
Mahase E. Covid-19: Oxford team begins vaccine trials in Brazil and South Africa to determine efficacy. BMJ. 2020;369:m2612.
Kupferschmidt K. ‘Vaccine nationalism’ threatens global plan to distribute COVID-19 shots fairly. 2020. https://www.sciencemag.org/news/2020/07/vaccine-nationalism-threatens-global-plan-distribute-covid-19-shots-fairly. Accessed 12 Aug 2020.
DeRoo SS, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458–9. https://doi.org/10.1001/jama.2020.8711.
Yamey G, Schäferhoff M, Hatchett R, Pate M, Zhao F, McDade KK. Ensuring global access to COVID-19 vaccines. Lancet. 2020;395(10234):1405–6.
World Health Organization. More than 150 countries engaged in COVID-19 vaccine global access facility. 2020. https://www.who.int/news-room/detail/15-07-2020-more-than-150-countries-engaged-in-covid-19-vaccine-global-access-facility. Accessed 12 Aug 2020.
Cohen J. The line is forming for a COVID-19 vaccine. Who should be at the front? 2020. https://www.sciencemag.org/news/2020/06/line-forming-covid-19-vaccine-who-should-be-front. Accessed 12 Aug 2020.
National Academy of Medicine, Engineering and Science. A framework for equitable allocation of vaccine for the novel coronavirus. https://www.nationalacademies.org/our-work/a-framework-for-equitable-allocation-of-vaccine-for-the-novel-coronavirus. Accessed 12 Aug 2020.
Bollyky TJ, Gostin LO, Hamburg MA. The equitable distribution of COVID-19 therapeutics and vaccines. JAMA. 2020. https://doi.org/10.1001/jama.2020.6641(Epub 7 May 2020).
Barnhard A. Language more normally suited to wartime is commonly invoked around the Covid-19 pandemic, but can we learn anything from past conflicts in our battle against coronavirus? 2020. https://www.bbc.com/future/article/20200430-covid-19-what-we-can-learn-from-wartime-efforts. Accessed 12 Aug 2020.
Nevins J. The imperative of personal sacrifice, today and during World War II. New York Times. 2020. https://www.nytimes.com/2020/04/03/magazine/personal-sacrifice-coronavirus-world-war-ii.html. Accessed 12 Aug 2020.
Department of Health and Social Care. Cost-Effectiveness Methodology for Immunisation Programmes and Procurement (CEMIPP) Report: the government’s decision and summary of consultation responses. Department of Health and Social Care; 11 Jun 2019.
Joint Committee on Vaccination and Immunisation. Code of Practice June 2013. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/224864/JCVI_Code_of_Practice_revision_2013_-_final.pdf. Accessed 12 Aug 2020.
Joint Committee on Vaccination and Immunisation. Independent report: interim advice on priority groups for COVID-19 vaccination. 2020. https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi/interim-advice-on-priority-groups-for-covid-19-vaccination. Accessed 12 Aug 2020.
Bonaccorsi G, Pierri F, Cinelli M, Flori A, Galeazzi A, Porcelli F, et al. Economic and social consequences of human mobility restrictions under COVID-19. Proc Natl Acad Sci USA. 2020;117(27):15530.
Bärnighausen T, Bloom DE, Cafiero-Fonseca ET, O'Brien JC. Valuing vaccination. Proc Natl Acad Sci USA. 2014;111(34):12313–9.
Sattar N, Ho FK, Gill JMR, Ghouri N, Gray SR, Celis-Morales CA, et al. BMI and future risk for COVID-19 infection and death across sex, age and ethnicity: preliminary findings from UK biobank. Diabetes Metab Syndr. 2020;14(5):1149–51.
Briggs A. Estimating QALY lossess associated with deaths in hospital (COVID-19) [research note]. Avalon Health Economics. 2020. https://avalonecon.com/wp-content/uploads/2020/04/COVID-19-QALYs-v3.pdf Accessed 12 Aug 2020.
Brotherhood L, Kircher P, Santos C, Tertilt M. IZA DP no. 13265: an economic model of the COVID-19 epidemic: the importance of testing and age-specific policies. Bonn: IZA Institute of Labor Economics; 2020.
Eichenbaum MS, Rebelo S, Trabandt M. The macroeconomics of epidemics. NBER working paper no. 26882; 2020.
Glover A, Heathcote J, Krueger D, Rios-Rull JV. Health versus wealth: on the distributional effects of controlling a pandemic.' Mimeo. 2020. https://www.jonathanheathcote.com/healthwealth.pdf. Accessed 12 Aug 2020.
van Doorslaer E, Masseria C; the OECD Health Equity Research Group Members. Income-related inequality in the use of medical care in 21 OCED countries. OECD health working paper no. 14; 2004.
Cookson R, Drummond M, Weatherly H. Explicit incorporation of equity considerations into economic evaluation of public health interventions. Health Econ Policy Law. 2009;4(2):231–45.
Hansen P, Devlin N. Multi-criteria decision analysis (MCDA) in healthcare decision-making. Oxford: Oxford University Press; 2019.
Duncan NT. Immigration policymaking in the global era. New York: Palgrave Macmillan; 2012.
Neumann-Böhme S, Varghese NE, Sabat I, Barros PP, Brouwer W, Exel J, et al. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur J Health Econ. 2020;21:977–82.
Kolata G. Who gets the Covid-19 vaccine first? Here’s one idea. New York Times. 2020. https://www.nytimes.com/2020/07/23/health/coronavirus-vaccine-allocation.html. Accessed 12 Aug 2020.
White DB, Angus DC. A proposed lottery system to allocate scarce COVID-19 medications: promoting fairness and generating knowledge. JAMA. 2020;324(4):329–30.
Soekhai V, de Bekker-Grob EW, Ellis AR, Vass CM. Discrete choice experiments in health economics: past, present and future. PharmacoEconomics. 2019;37(2):201–26.